Please login to the form below

Not currently logged in
Email:
Password:

AZ licensing agreement with Aurobindo

Aurobindo Pharma has announced a licensing and supply agreement with AstraZeneca to supply certain generic products for emerging markets

Aurobindo Pharma has announced a licensing and supply agreement with AstraZeneca (AZ) to supply the Anglo-Swedish drugmaker with certain generic products to be sold in emerging markets.

The generics involved in the agreement include several solid dosage and sterile products and offer therapeutic care in such areas as anti-infectives, as well as covering conditions affecting the cardiovascular system (CVS) and the central nervous system (CNS).

Financial terms of the deal were not disclosed.

India-based Aurobindo manufactures generic pharmaceuticals and active pharmaceutical ingredients, with products marketed in over 125 countries.

This is Aurobindo's second deal with a major global pharmaceutical company to supply drugs for emerging markets following an agreement with Pfizer in 2009.

Speaking on the deal, Kaushik Banerjee, head of branded generics operations at AstraZeneca said "These agreements will enable us to extend the range of branded medicines we are able to offer patients in emerging markets, where we see continued opportunities to grow our business."

Aurobindo chairman P V Ramprasad Reddy said: “Aurobindo's proven track record in building strong, collaborative working relationships is a key driver for these strategic agreements with AstraZeneca which will accelerate our growth plans and support our earnings."

7th September 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...